Proteon Pharmaceuticals Secures 21 million Euro to Accelerate Growth

Proteon Pharmaceuticals today announced an investment of 21 million Euro to accelerate commercialization of its products, which aim to reduce the reliance on antibiotics within aquaculture and livestock farming. Proteon Pharmaceuticals uses bacteriophages to reduce the need for antibiotics, improve on-farm performance and increase the sustainability of protein production.

Read More »

Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution

Read More »